Search Results 3371-3380 of 25205 for oral
glucocorticoids (A short course of oral prednisone [≤ 14 days] is allowed) 8. History of active or chronic liver disease 9. Chronic or acute renal disorder
This is a phase 3, randomized, controlled, open-label, multicenter study of the oral formulation of dexamethasone plus IXAZOMIB compared with treatment ...
Oral inhibitors of Janus-associated kinase (JAK), Bruton's tyrosine kinase (BTK), or tyrosine kinase 2 (TYK2), including baricitinib, tofacitinib ...
... Oral and throat cancer, Laryngeal cancer, Skull base tumor, Oropharyngeal cancer. Show more areas of focus for Daniel J. Ma, M.D. ...
All women of childbearing potential will use an appropriate contraceptive method, including barrier method, oral contraceptive medication, contraceptive device ...
Learn what healthcare professionals look for when diagnosing mouth cancer. Find out about oral cancer treatments, including surgery, chemotherapy and ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Otolaryngology · Physical Medicine ...
Use of oral corticosteroids and unable or unwilling to stop use of oral corticosteroids within the previous two weeks and for the duration of the study.
The overall objective of this study is to examine if the strategy starting of the addition of a tsDMARD, oral targeted molecule medications will lead to ...
... oral corticosteroid (OCS) dose ≤ 7.5 mg/day of prednisolone or equivalent, following standard induction regimen for at least 3 months and within 6 months ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.